Cargando…

Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening

BACKGROUND: International professional organizations recommend aspirin prophylaxis to women screened high risk for preterm preeclampsia (PE) in the first trimester. The UK Fetal Medicine Foundation (FMF) screening test for preterm PE using mean arterial pressure (MAP), uterine artery pulsatility ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moungmaithong, Sakita, Kwan, Angel H., Tse, Ada W., Wong, Natalie K., Lam, Michelle S., Wang, Jing, Poon, Liona C., Sahota, Daljit S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332599/ https://www.ncbi.nlm.nih.gov/pubmed/37428792 http://dx.doi.org/10.1371/journal.pone.0288289

Ejemplares similares

Performance of Fetal Medicine Foundation algorithm for first trimester preeclampsia screening in an indigenous south Asian population
por: Prasad, Smriti, et al.
Publicado: (2021)

Maternal Serum and Amniotic Fluid Inhibin A Levels in Women who Subsequently Develop Severe Preeclampsia
por: Kim, Shin-Young, et al.
Publicado: (2006)

Are serum levels of inhibin A in second trimester predictors of adverse pregnancy outcome?
por: Yue, Chao-Yan, et al.
Publicado: (2020)

Maternal Serum Activin A, Inhibin A and Follistatin-Related Proteins across Preeclampsia: Insights into Their Role in Pathogenesis and Prediction
por: Barrero, Jorge A., et al.
Publicado: (2023)

“Abnormal Analyte Preeclampsia”: Do the second trimester maternal serum analytes help differentiate preeclampsia subtypes?
por: CRITCHFIELD, Agatha S, et al.
Publicado: (2013)

Correlation of Maternal Serum Homocysteine in the First Trimester with the Development of Gestational Hypertension and Preeclampsia
por: Sun, Feng, et al.
Publicado: (2017)

Single-cell analysis reveals transcriptomic and epigenomic impacts on the maternal–fetal interface following SARS-CoV-2 infection
por: Gao, Lin, et al.
Publicado: (2023)

Serum Inhibin A and Inhibin B Levels in Epithelial Ovarian Cancer Patients
por: Walentowicz, Pawel, et al.
Publicado: (2014)

First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia
por: Bian, Zheng, et al.
Publicado: (2015)

Third‐Trimester Maternal Serum Chemerin and Hypertension After Preeclampsia: A Prospective Cohort Study
por: Chen, Yixuan, et al.
Publicado: (2023)

Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and Biomarkers
por: Malone, Sarah L, et al.
Publicado: (2022)

Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia
por: Torres-Torres, Johnatan, et al.
Publicado: (2023)

A study of the diagnostic value of Inhibin A Tests for occurrence of preeclampsia in pregnant women
por: Broumand, Farzaneh, et al.
Publicado: (2018)

Psychological Impact and Women’s Evaluation of the First-Trimester Pre-Eclampsia Screening and Prevention: ASPRE Trial
por: Nikčević, Ana V., et al.
Publicado: (2023)

Identification of novel first-trimester serum biomarkers for early prediction of preeclampsia
por: Liu, Mingxi, et al.
Publicado: (2023)

The predictive value of cervical shear wave elastography in the outcome of labor induction
por: Lu, Jing, et al.
Publicado: (2019)

Biomarkers at 6 weeks' gestation in the prediction of early miscarriage in pregnancy following assisted reproductive technology
por: Guo, Jun, et al.
Publicado: (2023)

Maternal Serum Meteorin Levels and the Risk of Preeclampsia
por: Garcés, María F., et al.
Publicado: (2015)

PAPP‐A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia
por: Neuman, Rugina I., et al.
Publicado: (2020)

First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach
por: Koster, Maria P. H., et al.
Publicado: (2015)

Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)
por: O'Gorman, Neil, et al.
Publicado: (2016)

First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
por: Austdal, Marie, et al.
Publicado: (2015)

A Normative Model of Serum Inhibin B in Young Males
por: Kelsey, Thomas W., et al.
Publicado: (2016)

Serum estradiol to testosterone ratio as a novel predictor of severe preeclampsia in the first trimester
por: Shen, Yongmei, et al.
Publicado: (2022)

Maternal Vitamin D Status in the Late Second Trimester and the Risk of Severe Preeclampsia in Southeastern China
por: Zhao, Xin, et al.
Publicado: (2017)

Differences in maternal soluble ST2 levels in the third trimester of normal pregnancy versus preeclampsia
por: Sasmaya, Prameswari Hawani, et al.
Publicado: (2021)

Combinatorial Analysis of Circulating Biomarkers and Maternal Characteristics for Preeclampsia Prediction in the First and Third Trimesters in Asia
por: Lin, Willie, et al.
Publicado: (2022)

Investigation of the relationship between changes in maternal coagulation profile in the first trimester and the risk of developing preeclampsia
por: Jin, Pei-Pei, et al.
Publicado: (2023)

Preeclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?
por: Rolnik, Daniel Lorber, et al.
Publicado: (2021)

Is maternal serum inhibin A a good predictor in preterm labor? - Experience from a community hospital in Taiwan
por: Huang, Shih-Yin, et al.
Publicado: (2020)

Integrating Combined First Trimester Screening for Preeclampsia into Routine Ultrasound Examination
por: Trottmann, Fabienne, et al.
Publicado: (2022)

Results of a Five-Year Experience in First Trimester Preeclampsia Screening
por: Capriglione, Stella, et al.
Publicado: (2022)

First-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety
por: Silang, Katherine, et al.
Publicado: (2023)

Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year
por: Lourenço, Inês, et al.
Publicado: (2020)

Measurement of retropubic tissue thickness using intrapartum transperineal ultrasound to assess cephalopelvic disproportion
por: Chor, Chung Ming, et al.
Publicado: (2018)

Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of ovarian hyperstimulation syndrome in IVF patients
por: Moos, Jiri, et al.
Publicado: (2009)

Association between risk of preeclampsia and maternal plasma trimethylamine-N-oxide in second trimester and at the time of delivery
por: Huang, Xin, et al.
Publicado: (2020)

Proficiency testing of maternal serum prenatal screening in second trimester in China, 2015
por: Zhang, Xiaoyan, et al.
Publicado: (2017)

A cohort study of the association between maternal serum Inhibin-A and adverse pregnancy outcomes: a population-based study
por: Singnoi, Wannaporn, et al.
Publicado: (2019)

Evaluation of first- and third-trimester afamin levels in preeclampsia
por: Gülücü, Selim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8v6q1kjgm14ndi5p3frk8io5v4